Table 3.
SF-36 physical health scale scores and 95% confidence intervals.*
| Physical Functioning† | Role Physical† | Bodily Pain† | General Health† | |||||
|---|---|---|---|---|---|---|---|---|
| N | Mean (95% CI) | N | Mean (95% CI) | N | Mean (95% CI) | N | Mean (95% CI) | |
| No history of cancer | 488,739 | 41.7(41.7–41.7) | 482,639 | 40.7(40.6–40.7) | 485,119 | 46.6(46.6–46.7) | 489,890 | 46.9(46.8–46.9) |
| Bladder | 1,296 | 40.5(39.9,41.2) | 1,280 | 38.5(37.6,39.4) | 1,290 | 46.1(45.5,46.6) | 1,302 | 45.0(44.4,45.5) |
| Melanoma | 1,157 | 41.9(41.3,42.5) | 1,148 | 40.4(39.5,41.3) | 1,150 | 46.7(46.1,47.2) | 1,163 | 46.9(46.3,47.4) |
| Uterus | 1,033 | 40.0(39.3,40.7) | 1,021 | 37.5(36.4,38.5) | 1,023 | 45.8(45.1,46.4) | 1,036 | 45.7(45.1,46.3) |
| Non-Hodgkin Lymphoma | 600 | 38.5(37.6,39.3) | 588 | 35.5(34.2,36.8) | 600 | 45.7(44.9,46.5) | 601 | 42.3(41.5,43.1) |
| Kidney | 439 | 40.4(39.5,41.4) | 433 | 38.0(36.5,39.4) | 435 | 44.4(43.4,45.3) | 440 | 44.1(43.2,45.0) |
| Cervix | 336 | 40.3(39.2,41.5) | 331 | 37.9(36.0,39.8) | 331 | 46.2(45.1,47.3) | 336 | 45.8(44.8,46.9) |
| Oral cavity & Pharynx | 388 | 39.5(38.4,40.6) | 374 | 37.3(35.7,38.8) | 378 | 45.8(44.8,46.9) | 388 | 44.0(43.1,45.0) |
| Thyroid | 183 | 41.5(40.1,42.9) | 178 | 38.0(35.7,40.3) | 181 | 45.9(44.5,47.2) | 184 | 46.2(44.9,47.5) |
| Ovary | 208 | 39.0(37.5,40.5) | 204 | 34.5(32.3,36.7) | 204 | 45.2(43.9,46.6) | 209 | 42.7(41.3,44.1) |
| Upper Gastro-intestinal | 191 | 38.8(37.2,40.4) | 190 | 35.2(32.9,37.5) | 190 | 45.9(44.2,47.3) | 191 | 42.2(40.8,43.7) |
| Chronic Leukemia | 189 | 40.1(38.6,41.5) | 186 | 37.6(35.2,40.0) | 186 | 45.6(44.2,46.9) | 189 | 42.1(40.7,43.6) |
| Multiple Myeloma | 110 | 34.4(32.3,36.4) | 110 | 28.9(26.3,31.6) | 110 | 40.0(38.0,42.1) | 110 | 36.9(35.0,38.9) |
| Pancreas | 65 | 38.1(35.2,40.9) | 65 | 31.4(27.7,35.2) | 65 | 43.2(40.4,46.1) | 65 | 39.3(36.8,41.7) |
*
Scores are adjusted for 
, whether cancer patient had a multiple cancers (yes/no), continuous age at first cancer diagnosis or first survey if no cancer, 12 chronic medical conditions, education, gender, marital status, race/ethnicity, income, whether or not a proxy completed the survey, cohort 1 vs. others, and mode of administration (mail or telephone).
†
Bolded scores represent a minimally important difference (3.0+) between the mean subscale score for cancer survivors vs. individuals without cancer.